What Himed does

Himed is a privately held U.S. biomaterials manufacturer founded in 1991 and headquartered in a 25,000 sq. ft. facility in Old Bethpage, New York. The company is a subsidiary within the Barson Composites Corporation family of businesses and specializes in calcium phosphate (CaP) biomaterials and biocompatible surface treatments for medical implant manufacturers serving dental, orthopedic, and spinal applications. Its product portfolio spans raw biomaterial inputs — hydroxyapatite (HA) powders, beta-tricalcium phosphate (β-TCP), HA whiskers, calcium phosphate discs, and cast HA shapes — alongside its proprietary MATRIX® line of surface treatments: MATRIX HA® (plasma-sprayed hydroxyapatite coating), MATRIX MCD® (resorbable blast media micro-abrasive blasting), MATRIX Dual® (two-step surface texturing), MATRIX Color® (Type III color anodizing), and MATRIX Ti® (air-plasma titanium spray). Underlying technology centers on calcium phosphate chemistry and proprietary plasma-spray and abrasive-blasting methods, with MCD Apatitic Abrasive (invented 1994) recognized as a biocompatible, resorbable blast media that leaves no embedded residue — a differentiator versus conventional aluminum oxide or glass bead media.

Himed monetizes through three primary streams: (1) sale of raw biomaterials to OEM manufacturers for in-house production, (2) contract surface treatment services performed at its New York facility, and (3) contract R&D and prototyping services through the Bioceramics Center of Excellence (BCoE), launched in 2024 with Lithoz LCM 3D printing capability. Pricing is quote-based and tailored to customer specifications rather than catalog-published. Go-to-market is enterprise B2B field sales — direct engagement with engineering and quality teams at medical device manufacturers, supplemented by an exclusive distribution relationship with I&H Global in South Korea (since 2010) and by thought-leadership marketing via technical white papers, trade shows (AAOS, OMTEC, NASS, Rapid+TCT), and earned media coverage. The company holds ISO 13485:2016 certification (maintained 16+ consecutive years) and FDA registration under 21 CFR 820, enabling it to support Class I, II, and III medical device manufacturing customers globally across six continents.

Name

Himed

Legal name

Himed

Website

https://himed.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Short description

Himed is a U.S. biomaterials manufacturer founded in 1991 (subsidiary of Barson Composites Corporation) that supplies calcium phosphate powders, proprietary MATRIX® surface treatments, and contract R&D services to dental, orthopedic, and spinal medical device manufacturers globally.

Ownership category

akta.pro rank

Product category

Medical Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)

akta.pro secondary industries

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG), 3D Bioprinting & Biofabrication (HLAAAGAC), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI)

Keywords

• Calcium phosphate biomaterials
• Implant surface treatments
• Medical device coatings
• Osseointegration materials
• Bioceramic materials

Headquarters

HQ city

Old Bethpage

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Raw Biomaterials Sales: Sale of calcium phosphate powders, granules, and forms to medical device manufacturers for in-house production use. Products include hydroxyapatite powders, beta-tricalcium phosphate, and custom CaP compounds.
2. Surface Treatment Services: Contract manufacturing services for implant surface texturing and coating using MATRIX® processes including MCD abrasive blasting, HA coating, color anodizing, and titanium plasma spray. Performed at New York facility for customer products.
3. Contract R&D Services: Analytical and R&D services through the Bioceramics Center of Excellence including materials testing, bioink development, and 3D printing prototyping for calcium phosphate applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Himed manufactures and supplies medical-grade calcium phosphate biomaterials (hydroxyapatite powders, beta-tricalcium phosphate, whiskers, discs, cast shapes, and MCD Apatitic Abrasive) and provides proprietary MATRIX® surface treatment services—including hydroxyapatite coatings, micro-abrasive blasting, dual texturing, color anodizing, and titanium plasma spray—for dental, orthopedic, and spinal implant manufacturers. The company also operates the Bioceramics Center of Excellence™, offering contract R&D, analytical testing, and 3D bioprinting prototyping using Lithoz LCM technology with custom calcium phosphate bioinks.

Product overview

Himed is a global supplier of medical biomaterials offering a comprehensive portfolio of calcium phosphate powders, forms, abrasives, and surface coatings. The company's product ecosystem consists of raw biomaterial inputs (hydroxyapatite powders, β-TCP, whiskers, discs, cast shapes) and its proprietary MATRIX® line of surface treatment systems including MATRIX HA® (hydroxyapatite coatings), MATRIX MCD® (apatitic abrasive blasting), MATRIX Dual® (dual-texturing), MATRIX Color® (color anodizing), and MATRIX Ti® (titanium plasma spray). The Bioceramics Center of Excellence provides contract R&D and prototyping services including custom bioinks for ceramic 3D printing. All products support dental, orthopedic, and spinal implant applications for medical device manufacturers.

Differentiator

Problem solved

Functional benefit

Brands

• MATRIX®: Line of surface treatment systems including MATRIX HA® (hydroxyapatite coatings), MATRIX MCD® (apatitic abrasive blasting), MATRIX Dual® (micro-scale morphology), MATRIX Color® (color anodizing), and MATRIX Ti® (titanium plasma spray).
• Bioceramics Center of Excellence™ (BCoE)
• MATRIX HA®
• xFAB

Products and services

• Hydroxyapatite (HA) Powders Medical-grade hydroxyapatite powders available in various sizes with varying surface morphology dependent on method of manufacture. Used for medical implant coatings, bone cements, synthetic bone grafts, and laboratory substrates. Manufactured at Himed's 25,000 sq. ft. facility in New York.
• MATRIX HA® Coating Air plasma applied textured hydroxyapatite coating for titanium and titanium-alloy implants that enhances osseointegration and biocompatibility for dental, orthopedic, and spinal implants. Proprietary to Himed with documented IP.
• MATRIX MCD® Micro-Abrasive Blasting Service Proprietary micro-abrasive blasting process using calcium phosphate-based apatitic abrasive for post-processing titanium, titanium alloy, and PEEK surfaces. Creates uniform micro-porosity for better osseointegration without residual contamination.
• MATRIX Dual® Surface Texturing Service Two-step surface texturing process that expands the micro-scale morphology potential of orthopedic implants using apatitic abrasive blasting to achieve complex, highly uniform macro and micro surface morphology on titanium implants.
• MATRIX Color® Type III Color Anodizing Service Fully automated color anodizing process providing a complete range of colors for titanium implants and related components. Creates vibrant, aesthetically unique surfaces with biocompatibility benefits, useful for part identification.
• MATRIX Ti® Titanium Plasma Spray Service Patented titanium coating process using unique air-plasma spray solution for highly-textured Ti surfaces with less cost and faster production times compared to conventional vacuum applied methodologies, providing controlled porosity and texture.
• MCD Apatitic Abrasive Award-winning biocompatible, resorbable blast media (RBM) composed of calcium phosphates (hydroxyapatite and tricalcium phosphate). Ideal for post-processing titanium, titanium alloy, and PEEK surfaces. Available in various granule sizes. Winner of the 2023 BIOMEDevice Judges' Choice Award.
• Calcium Phosphate Discs Enamel-like hydroxyapatite discs in various configurations used by universities and research labs around the world for testing and research applications.
• Hydroxyapatite Whiskers 100% pure single-crystal hydroxyapatite rod-like particles used for strengthening bioactive scaffold materials and PEEK composites.
• Cast HA Shapes Intricate porous scaffolds of hydroxyapatite and biphasic compounds, available as conventionally cast or 3D-printed forms including custom blocks, granules, spheres, and cast teeth forms.
• Beta-tricalcium phosphate (β-TCP) Calcium phosphate biomaterial with bioresorbable properties used in 3D printing and bone filler applications.
• Bioceramics Center of Excellence™ (BCoE) Contract research and development center providing analytical services, materials testing, and bioceramics 3D printing prototyping. Enables medtech companies to leverage Himed's materials expertise to refine 3D-printed bioceramic designs and develop calcium phosphate bioinks.
• Calcium Phosphate Bioinks Custom bioink formulations developed by Himed for Lithoz LCM 3D printers using unique calcium phosphate compounds for improved medical and dental implant osseointegration.

Quantifiable outcome

• MCD abrasive achieves Ra surface roughness of 1.0μm–3.2μm while preserving critical tolerances and shape details
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Adva CeracoreStrategic or Co-development Partner · 27 May 2026Strategic partnership to create a complete development-to-production pathway for 3D-printed calcium phosphate components used in dental, orthopedic, and spinal applications. The partnership builds on Himed's 2024 Bioceramics Center of Excellence, enabling customers to transition from prototype to production-scale additive manufacturing without requalifying materials. The ceramics 3D printing sector is projected to grow to nearly $900 million by 2033. The partnership offers a fully domestic, vertically integrated pathway from R&D through serial production.
• LithozcoreTechnology or Integration · 1 January 2023Vienna-based partnership to develop new bioink materials for Lithoz's LCM 3D printers using unique calcium phosphate compounds for improved medical and dental implant osseointegration. Lithoz is a leading manufacturer of ceramic 3D printing systems.
• Mercury BiominorStrategic or Co-development Partner · 1 January 2023Research partnership to explore development of novel osteogenic materials that employ chimeric extracellular vesicles. Himed seeks to explore frontiers of organic CaP integrations at the molecular level using Mercury Bio's advanced drug delivery system.
• Alfred University - New York State College of CeramicsminorStrategic or Co-development Partner · 1 January 2021Multi-year collaborative research agreement to advance and optimize techniques used in the production of calcium phosphate biomaterials. Aims to advance understanding of synthesis and production of critical biomaterials for dental, orthopedic, and bone grafting applications.
• I&H GlobalcoreChannel Partner/ Reseller/ Distributor · 1 January 2010Exclusive sales representative in South Korea since 2010. I&H Global was founded to raise awareness about biomaterials like hydroxyapatite in medical implants and has connected Korean dental and orthopedic manufacturers with Himed's materials and surface treatments. The partnership celebrated 15 years in 2025.
• Barson Composites CorporationcoreOthers · 1 January 1991Parent company of the Barson family of businesses. Himed was originally founded due to increased demand for calcium phosphate coatings at Hitemco, another Barson Company specializing in high-performance coating characterization. Barson Composites Corporation holds businesses in biomaterials, medical device, aerospace, and pharmaceutical industries.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• CAM Bioceramics: CAM Bioceramics is a Netherlands-based manufacturer of calcium phosphate bone substitutes and coatings used in orthopedic, dental, and spinal applications. It is one of the most directly comparable competitors to Himed, offering hydroxyapatite and other CaP-based products to medical device OEMs globally.
• Berkeley Advanced Biomaterials (BAB): BAB manufactures bioresorbable calcium phosphate bone graft substitutes and synthetic bone grafting materials serving dental, orthopedic, and cranio-maxillofacial markets. It competes directly with Himed's hydroxyapatite and β-TCP product lines in the medical biomaterials supply market.
• Curasan: Curasan AG is a German specialist in regenerative biomaterials, producing synthetic bone graft substitutes and dental bone regeneration products. It is directly comparable to Himed in the calcium phosphate bone graft and dental biomaterials space.
• APS Materials: APS Materials produces plasma-sprayed bioceramic coatings including hydroxyapatite and titanium coatings for orthopedic and dental implants. It offers overlapping surface treatment capabilities to Himed's MATRIX HA and MATRIX Ti product lines, serving similar medical device OEM customers.
• Plasma Biotal: Plasma Biotal is a UK-based provider of hydroxyapatite and bioceramic coatings for orthopedic, dental, and trauma implants. It competes with Himed in plasma-sprayed HA coatings and related implant surface treatments for medical device manufacturers.
• OSARTIS: OSARTIS is a German biomaterials company producing bone cements, calcium phosphate bone substitutes, and resorbable implant materials. It serves orthopedic and trauma surgery markets with comparable calcium phosphate-based products to Himed's HA and β-TCP offerings.
• DOT GmbH: DOT GmbH is a German manufacturer of PEKK and polymer-based implant materials used in spinal and orthopedic applications. It is comparable to Himed in serving implant surface treatment and biomaterial supply for spinal and orthopedic device manufacturers, with overlapping calcium phosphate and polymer material expertise.

Regional players

• CGBio: CGBio is a South Korean biomaterials company specializing in bone graft substitutes, dental bone regeneration, and tissue engineering products. It is a regional peer to Himed, operating in the Korean market where Himed partners with I&H Global for sales representation.

Others

• Lithoz: Lithoz is an Austrian manufacturer of ceramic 3D printing systems (LCM technology) and a strategic partner of Himed for bioink development. While not a direct competitor, Lithoz is an ecosystem peer in the 3D bioceramic printing space, with overlapping customer bases among dental and orthopedic implant developers.

Emerging players

• AdvaCera: AdvaCera is a partner of Himed for serial production of 3D-printed calcium phosphate medical devices in dental, orthopedic, and spinal applications. As an emerging production-scale player in bioceramic additive manufacturing, it is comparable to Himed's expanding 3D bioceramic capabilities via the Bioceramics Center of Excellence.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks2 records

Key highlights7 records

Customer concentration

• Xx.com/himedbio

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Himed